DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties.
Dual oxidase 1 (DUOX1) is an oxidant-generating enzyme within the airway epithelium that participates in innate airway host defense and epithelial homeostasis. Recent studies indicate that DUOX1 is suppressed in lung cancers by epigenetic silencing, although the importance of DUOX1 silencing in lung cancer development or progression is unknown. Here we show that loss of DUOX1 expression in a panel of lung cancer cell lines is strongly associated with loss of the epithelial marker E-cadherin. Moreover, RNAi-mediated DUOX1 silencing in lung epithelial cells and the cancer cell line NCI-H292 was found to result in loss of epithelial characteristics/molecular features (altered morphology, reduced barrier function and loss of E-cadherin) and increased mesenchymal features (increased migration, anchorage-independent growth and gain of vimentin/collagen), suggesting a direct contribution of DUOX1 silencing to epithelial-to-mesenchymal transition (EMT), an important feature of metastatic cancer. Conversely, overexpression of DUOX1 in A549 cells was capable of reversing EMT features. DUOX1 silencing in H292 cells also led to enhanced resistance to epidermal growth factor receptor tyrosine kinase inhibitors such as erlotinib, and enhanced levels of cancer stem cell (CSC) markers CD133 and ALDH1. Furthermore, acquired resistance of H292 cells to erlotinib resulted in enhanced EMT and CSC features, as well as loss of DUOX1. Finally, compared with control H292 cells, H292-shDUOX1 cells displayed enhanced invasive features in vitro and in vivo. Collectively, our findings indicate that DUOX1 silencing in lung epithelial cancer cells promotes features of EMT, and may be strongly associated with invasive and metastatic lung cancer.
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
A C
AC
Little
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
D
D
Sham
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
M
M
Hristova
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
K
K
Danyal
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
D E
DE
Heppner
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
R A
RA
Bauer
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
L M
LM
Sipsey
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
A
A
Habibovic
Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.|Vermont Lung Center, College of Medicine, University of Vermont, Burlington, VT, USA.
A
A
van der Vliet
Oncogene. 2005 Nov 14;24(50):7443-54
16288291
Mol Cancer Res. 2009 Mar;7(3):330-8
19276181
J Clin Oncol. 2013 Mar 10;31(8):1061-9
23401452
Cancer Res Treat. 2012 Sep;44(3):151-6
23091440
Nat Cell Biol. 2006 Nov;8(11):1291-7
17028578
Cancer Res. 2005 Oct 15;65(20):9455-62
16230409
Antioxid Redox Signal. 2009 Oct;11(10):2453-65
19358684
Oncogene. 2013 Apr 18;32(16):2016-26
22710722
Cell Stem Cell. 2011 Jun 3;8(6):639-48
21624809
EMBO Rep. 2010 Sep;11(9):670-7
20706219
J Thorac Dis. 2010 Sep;2(3):154-9
22263037
Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1549-61
16987010
Am J Cancer Res. 2014 Sep 06;4(5):508-17
25232492
Oncogene. 2009 Oct 29;28(43):3801-13
19684613
Am J Respir Cell Mol Biol. 2013 Mar;48(3):337-45
23239498
J Clin Invest. 2009 Jun;119(6):1420-8
19487818
Cancer Res. 2013 May 15;73(10):3051-61
23542356
Nat Rev Cancer. 2012 Sep;12(9):627-37
22918415
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15535-40
20713723
Adv Cancer Res. 2014;122:1-67
24974178
Cancer Res. 2014 Mar 1;74(5):1554-65
24436149
Clin Exp Metastasis. 2008;25(8):843-54
18696232
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5051-6
25848056
Free Radic Res. 2009 Jun;43(6):523-32
19431059
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
19478820
Sci Rep. 2016 Apr 15;6:24582
27079415
Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1249-52
16910772
J Biol Chem. 2007 Feb 2;282(5):3213-20
17135261
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22293-8
20007775
Cancer Sci. 2009 Aug;100(8):1382-8
19493276
PLoS One. 2013;8(1):e54391
23349873
Nat Cell Biol. 2009 Dec;11(12):1487-95
19935649
Cell Death Differ. 2008 Mar;15(3):504-14
18049477
Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1068-75
18375743
J Biol Chem. 2000 Jul 28;275(30):23227-33
10806195
Am J Physiol. 1994 May;266(5 Pt 1):L493-501
7515578
Eur J Cancer. 2009 Aug;45(12):2071-6
19523816
Cells Tissues Organs. 2011;193(1-2):8-22
21041997
Antioxid Redox Signal. 2014 Jun 10;20(17):2873-89
24156355
Oncogene. 2010 Aug 26;29(34):4741-51
20531305
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8686-98
16361555
Cancer Metastasis Rev. 2003 Dec;22(4):337-58
12884910
Cancer Res. 2008 Feb 15;68(4):1037-45
18281478
Cell Commun Signal. 2014 Jan 11;12:5
24410844
J Cell Biol. 2012 Oct 15;199(2):225-34
23045550
Int J Cancer. 2014 Dec 15;135(12):2962-71
24771540
Cell Cycle. 2014;13(20):3222-31
25485502
Radiother Oncol. 2013 Sep;108(3):370-7
23830194
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18171-6
16330757
PLoS One. 2011;6(10):e26552
22028904
Antioxid Redox Signal. 2009 May;11(5):1107-22
18999985
Redox Biol. 2016 Aug;8:24-7
26722841
J Allergy Clin Immunol. 2016 May;137(5):1545-1556.e11
26597162
Nat Rev Clin Oncol. 2009 Oct;6(10):587-95
19787002
J Carcinog. 2013 Dec 31;12:22
24574860